Paul Andrew Moore insider trades
Open-market stock purchases and sales by Paul Andrew Moore, Chief Scientific Officer at Zymeworks Inc, from SEC Form 4 filings since Jul 18, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 12, 2026 | ZYME Zymeworks Inc | Bought (not open market) | — |
| Jan 12, 2026 | ZYME Zymeworks Inc | Bought (not open market) | — |
| Jan 12, 2026 | ZYME Zymeworks Inc | Bought (not open market) | — |
| Jan 12, 2026 | ZYME Zymeworks Inc | Sold | $217K |
| Jan 12, 2026 | ZYME Zymeworks Inc | Bought (not open market) | — |
| Jan 5, 2026 | ZYME Zymeworks Inc | Sold | $233K |
| Jan 5, 2026 | ZYME Zymeworks Inc | Sold | $272K |
| Jan 5, 2026 | ZYME Zymeworks Inc | Bought (not open market) | — |
| Jan 5, 2026 | ZYME Zymeworks Inc | Bought (not open market) | — |
Companies traded
- ZYME Zymeworks Inc: 7 sales, last Jan 12, 2026